Study identifies a new biomarker for Alzheimer’s disease in asymptomatic stages

FHS
May 15, 2024
8:23 pm

A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona has identified a new biomarker for Alzheimer’s disease in asymptomatic stages of the disease.

China grants approval for GenFleet’s fulzerasib to treat lung cancer

The treatment is indicated for NSCLC patients who have received a minimum of one systemic therapy previously. Credit: 19 STUDIO/Shutterstock. The National Medical Products Administration

August 26, 2024

Targeting the gut microbiome: A new approach to treating diabetes

Researchers review the role of gut microbiota in the pathogenesis and management of diabetes mellitus.

June 24, 2024

Experts’ Hopes for the Future of dMMR Uterine Cancer Treatment

In this exclusive MedPage Today video, Susana Campos, MD, from the Dana-Farber Cancer Institute in Boston, and Richard Penson, MBBS, of Mass General Cancer Center

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.